Germany vs Togo: Estimated antiretroviral therapy coverage among people living with HIV
Germany
91.0%
in 2024
Togo
93.0%
in 2025
Germany rank
15th
Togo rank
14th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Germany
- Togo
How they compare
Togo currently reports 93.0% against 91.0% in Germany, a difference of 2.0%.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Germany ahead.
Germany ranks 15th and Togo ranks 14th of 143 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Germany | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.9% | 40.3% | 38.6% | Germany |
| 2020s | 91.0% | 81.4% | 9.6% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Germany or Togo?
- Togo, at 93.0% against 91.0% in Germany as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Germany and Togo?
- 2.0%, with Togo ahead.
- How many years of comparable data are there for Germany and Togo?
- 15 years are reported by both, from 2010 to 2024.
- How do Germany and Togo rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Germany ranks 15th and Togo ranks 14th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.